Ptc299, A Novel Regulator Of Tumor Vegf Expression, Is Well Tolerated And Achieves Target Plasma Concentrations: Dose-Ranging Results Of A Phase 1b Study In Women With Metastatic Breast Cancer.
CANCER RESEARCH（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要